Research from the University of California, Irvine revealed how disruption of the circadian clock may accelerate the progression of colorectal cancer by affecting the gut microbiome and intestinal barrier function.
Mainz Biomed, a molecular genetics diagnostic company specializing in the early detection of cancer, announced a collaborative agreement with Thermo Fisher Scientific Inc. through its subsidiary Life Technologies Corporation.
